December 27, 2014 5:12 PM ET

Biotechnology

Company Overview of Immunovative Therapies Ltd.

Executive Profile

Emmanuel Katsanis M.D.

Chairman of the Scientific Advisory Board, Chief Medical Officer and Medical Monitor, Immunovative Therapies Ltd.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Emmanuel Katsanis, M.D. served as Chairman of Scientific Advisory Board, Chief Medical Officer and Medical Director of Immunovative Therapies Ltd. since July 2012. Dr. Katsanis provides medical guidance, strategic advice and oversight of ITL's worldwide clinical development programs, including selection of target indications, protocol design and design of immunological monitoring end-points. He also serves as Chairman of Scientific Advisory Board, Chief Medical Officer ...

Corporate Headquarters

P.O. Box 974
Shoham, -- 60850

Israel

Phone: --
Fax: 972 3 970 2090

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Immunovative Therapies Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.